Centad LOGO
  
   Home      RSS/XML Feed      Contact      Site Map      Donation  
ABOUT CENTAD MEDIA & NETWORK PROGRAMMES DEMYSTIFYING TRADING PUBLICATION

Report of the Centad’s Presentation at the Conference on “Publicly Funded Patents and Technology transfer: A Review of the Indian Bayh Dole” organized by NUJS, Kolkata

The West Bengal National University of Juridical Sciences- NUJS- (NUJS IPR Chair with IPTLS and Share) organised a conference on “Publicly Funded Patents and Technology Transfer: A Review of the Indian Bayh Dole” on the 12th of September 2009 at the NUJS Auditorium, Salt Lake, Kolkata. In January 2009, the government introduced the Protection and Utilisation of Public Funded Intellectual Property Bill, 2008 in the Rajya Sabha. The bill is currently undergoing scrutiny by a Parliamentary select committee, after which it will be placed before the Parliament.  This conference aimed to generate more awareness and a nuanced discussion around the Bill and what is stands for.

Speaking at the concluding panel discussion, Yogesh Pai, Associate Fellow at the Centre for Trade and Development (Centad), New Delhi brought out some of the major flaws in the current version of the Bill. He scoped them as issues that involve a broader policy dimension and those that relate specifically to the language and scope of the Bill, which might led to unintended consequences. He noted that there were inherent problems with the way in which the Bill came to be drafted. He emphasized that the bill was shrouded in secrecy right since its inception and there ought be have been greater transparency in the drafting process of the Bill. Noting that there was no background study conducted- except on the recommendation by the National Knowledge Commission (NKC), which directly works under the leadership of the Hon’ble Prime Minister- he vehemently argued for the need to conduct a rigorous and evidence based study on issues around this bill before its endorsement by the Indian Parliament. The recommendations of the NKC, he noted, was shoddy and highly misleading since it was based on an outdated, flawed and orthodox understanding of the importance of IPRs and its links with the innovation ecosystem and commercialization in an university or public funded institutional environment. He emphasized on the need to promote a holistic view about how the innovation ecosystem performs in a publicly funded research environment and its relationship with commercialization for better and affordable products reaching the Indian consumers- especially affordability of medicines by the larger section of the Indian public. It was indeed unfortunate that when the whole IP system in under tremendous stress and challenge, this bill would add to worsening of the situation by fully endorsing the idea that more patents meant more innovation. And this is even while there is concrete evidence quite to the contrary formulated by experts in evidentiary IP research , also confirmed by reports from the EPO, special UN expert commissions and the Competition Commissions across the globe. He noted that while there is a strong ongoing global attempt to propose a compensatory liability regime in case of patents and copyrights, it was disturbing to note a reverse trend of IP fundamentalism in India. He noted that wider diffusion of technologies was the need of the hour, which could only be possible if the IP holders did not possess any legal backing to unilaterally refuse the license and to unilaterally fix royalties that lead to possible royalty staking situations.

He specifically emphasized that since IPRs were private rights to be protected under international agreements- more specifically under the TRIPS agreement- there is an opportunity to carve out a indigenous regime for promoting innovation in cases of public funded research environment as there are no private rights involved in the first place. Publicly funded patents may have their own set of standards for patent eligibility, patentability, acquisition and enforcement and no international commitment would act as deterrent to it. In this context, the speaker emphasized on the need to understand that in case of publicly funded IPRs, India could broadly interpret limitations and exceptions, notwithstanding her current commitment under any international IP agreements. He also cautioned on the need to consider the changing norms of science  which would fundamentally be altered if  the IP culture overrides the scientific culture of sharing and growing. In fact, the whole direction of research may take a different course, more so in case of neglected diseases where even with adequate IP protection, private R&D fails due to produce new drugs due to the enduring phenomenon of “missing markets”. He hypothesized that the promise of  needs driven scientific research and development by publicly funded research institutions may be successfully trumped by greed driven scientific research.

Another important lacuna in the Bill relates to the issue of tracking commercialization. While the bill was aimed at commercialization, it did no attempts in provisioning the same except for a local working clause. This, the speaker noted, might not in all cases ensure commercialization. The assignees of patents may for obvious competitiveness factors sit on the research outcomes without taking active measures to commercialize the invention, even while keeping the patents alive and royalties flowing to the inventor and the institution. Hence there is a need to carve out a regulatory model to ensure commercialization where genuine non-feasibility issue is not involved. Further, he emphasized on the need to cast some liability on the IP Management Committees (IPMC) for irresponsible decision making behavior. While the bill stipulates strict penalties for all actors, interestingly one of the major beneficiaries – the IPMC- was left with no liability!  Next, in cases where the recipient (the university or publicly funded institution) does not opt for title, is there any need for establishing the IPMC?- the bill does no attempt to provide any clarity. Further, the speaker noted that there might be situations where students (specifically masters and PhD students) are engaged by the university/inventors to conduct research. Such students may not be employed or engaged by the institution for conducting the specific research and might be working on educational grants. Since inventions arising out of educational grants are excluded from the purview of the bill, some inventions created by students in public funded institutions may not be recognized at all.

On some of the more specific points concerning the Bill and its language, he pointed that there were visible gaps which might lead to litigious waste and have long term negative impacts. He noted that scientific innovation demands sharing (material sharing and knowledge sharing) and that the bill failed to promote inter-university/public funded institute technology transfer and licensing arrangements. He pointed that the bill makes no fundamental distinction between the use of publicly funded IP by the industry versus another public funded university. Noting that the research exemption in India, though broadly worded, might be narrowly construed under the influence of jurisprudence that has emerged in comparative developed country jurisdictions. Hence it might not resolve the issue of promoting inter-university knowledge flows and technology transfer, especially when the research outcome is commercialized. Another provision relating to licensing of related patents under section 91 under the Patents Act is also of limited help since the basic condition for such a licensing arrangement works only in case of patents holders holding cross portfolios, including other additional stipulations attached. The speaker then stressed on the need to internalize the concepts of competition law to create an overarching framework for knowledge dissemination. Wider and broader use of essential facilities doctrine under the abuse of dominance prong of the modern competition law, he noted, could be of useful help.  He stressed on the need to internalize provisions in the bill relating to competition law on ex ante basis without resorting to ex post treatment under competition law, which could potentially mitigate the negative impacts of the bill- more specifically with reference to inter- inter-university/public funded institute technology transfer and licensing arrangements. Emphasizing that specific and legally sophisticated regime for Patent pledges (covenants not to sue) could also be carved within the scope of this bill, he noted that it could in some instances lead to voluntary upfront commitments by IP owners/ inventors.

He concluded with a general remark that the bill in its current version was fundamentally flawed and urged upon the need to reconsider altering its fundamentals before it’s too late to recall!

The Panel Discussion (L to R): Dr. V K Unni, IIM Kolkata; Prof. Madhukar Sinha,  IIFT- New Delhi; C H Unnikrishnan, LiveMint; Yogesh Pai, Centad- New Delhi;

Pranesh Prakash, CIS- Bangalore; Prof. (Dr.) N S. Gopalakrishnan, HRD IPR Chair CUSAT-Cochin; Prof. Shamnad Basheer, HRD IPR Chair- NUJS Kolkata.

 
top
 Print this Article
  Email this page 
 Archives 

 
 
  More Events 
Conference on Gender Equality and Social Justice: Presentation by Centad
Patents and Platform Technologies: Understanding Implications for Research and Development in Malaria and Tuberculosis
Report on National Consultation-Free Trade Policies and Impact on Sustainable Development, Social and Gender Justice: A Case Study of the EU-India Trade Relations
Special Talk by Dr. Martin Khor entitled "Cut or Not to Cut: Does Development have a Chance?
Report on the Centad's Team's Feedback to IMF reforms
Report of the Interactive Session with Prof. Philipe Cullet, Reader in the Deptt. of International Environment Law, SOAS University, UK.
Report of the Centad’s participation in the National Seminar on “Geograhical Indications” where do the Indian interests lie?
Consultation Meeting on Price Negotiations of Patented Medicines
Discussion Meeting on: "EU Competition Commission's Report on the Pharmaceutical Sector: What Lessons for India?"
India’s Submission to the UNFCCC on Climate Change Negotiations
Event Report of the Lecture Titled “Global Financial Crisis: An Optimistic Scenario”
Universal Access and Rational Therapy
A Dissemination Workshop of Tracing Pharmaceuticals in South Asia (TPSA)
National Conference on “Copyright Law: Limitations and Exceptions”
Report of the Strategy Meeting of Civil Society Organisations held at Copenhagen from May 12-15, 2009
1st Briefing and Consultative Meeting on Select Agenda Items of the 62nd World Health Assembly, 2009
Centad Beats a Drum to celebrate World Fair Trade Day
Report on Asia Regional Dialogue on Trade and Climate Change - held at Bangkok, Thailand on April 30 to May 1 , 2009
The Proposed EU India FTA and Effect on Vulnerable Groups in India: Some Issues
Report of Seminar on "The Food Question in the Time of Crises : The Policy Discourse for the Developing World" held on 11 April 2009
"Report on National Consultation on Access to Treatment for the People Living with HIV/AIDS" Coorganised by PRAYAS, Jaipur and Centad
Capacity Building Programme on Georgaphical Indicators
Report on Civil Society Consultation for World Bank Climate Change Strategy for South Asia
Brain Storming Session on "Small scale Pharmaceutical Industry- Problems and Prospects"
Report on the Climate Change Congress Report - Copenhagen, Denmark March 10-12, 2009
Report on Interactive Meeting with CITI - Impact of Recession on Indian Textile Industry
4th South Asia Conference on Trade and Development 2008 : ‘Trading in Development? Emerging Issues in South Asia’
Advanced Technical Briefing Seminar on Medicine Prices, Availability and Price Regulation
National Consultation on Climate Change : A Vision for South Asia  
Global Financial Crisis: Implications for India
Seminar on Medicine Prices, Availability and Price Regulation
Report on the Workshop on “WTO Negotiations and the Way Forward”
Seminar on High Food Prices and Development Challenges
Workshop on Definition of New Chemical Entities: Implications for Flexibilities in Patent and Drug Regulatory Laws
One-day National Consultation on Access to Medicines in India
Update Meet on the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property
Consultation on Doha to Accra: Does development have a chance?
The Consultation on the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property
Round Table on Current Developments in the Work of WHO IGWG
Workshop on Patent Pre-grant Opposition In India
Workshop on Trade and Access to Medicines
Consultation on the Examination of Pharmaceutical Patents
South Asian Conference on Trade and Development 2007
Press release- Kamal Nath's statement at Centad's South Asian conference on Trade & Development 2007
Exploring New Regionalism: The EU, India and Beyond
Symposium on ‘Climate Change and India: Run-up to Bali’
International Conference on Exploring 'New Regionalism': The EU, India & beyond
Brainstorming meeting on Indo-EU FTA: Issues and Concerns
Workshop on building trade safety nets in agricultural systems, in South Asia
National consultation on consumer drug information in India: A situational analysis
Interactive session on ‘Mashelkar Committee Report on Patent Laws’
Release of South Asian Yearbook of Trade and Development 2006
South Asian Conference on Trade and Development
International seminar on ‘India and the New Global Intellectual Property Rights (IPR) Regime'
Symposium on ‘The Doha Impasse: Which way are we headed?’
‘WTO and South Asia: Strategising beyond Hong Kong’
National Consultation on 'WTO and India: Strategising Beyond Hong Kong'
Debate on ‘Does the WTO undermine the sovereignty of nations?’
International seminar on Multi-Fibre Agreement
Centad-PHDCCI symposium on ‘The Doha Round after Hong Kong: Where does India stand?’
Centad facilitates BBC Radio programme on globalisation
Workshop on 'Use of International Non-proprietary Names in India'
 
 
Centre for Trade & Development |A1/304 Safdarjung Enclave| New Delhi 110029
Tel: +91-11-41459226 Fax: +91-11–41459227
© Copyright 2005-10 Centad | Disclaimer
Registered under Societies Act as Consortium for
Trade and Development